{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:42:53Z","timestamp":1793234573806,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460587"],"award-info":[{"award-number":["82460587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172989"],"award-info":[{"award-number":["82172989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273068"],"award-info":[{"award-number":["82273068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development projects in Jiangxi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>N4-acetylcytidine (ac4C) is a recently identified mRNA modification, with N-acetyltransferase 10 (NAT10) being the sole known enzyme responsible for its catalysis. However, the biological functions and regulatory mechanisms of NAT10-mediated ac4C modification in glioblastoma (GBM) remain largely unclear. In this study, we aimed to elucidate the regulatory pathways and functional implications of NAT10 and ac4C modification in GBM. We found that NAT10 is significantly upregulated in GBM, and its elevated expression is associated with disease progression and poor patient prognosis. Functionally, NAT10 promotes glioblastoma cell proliferation and migration in vitro and accelerates tumor growth in vivo. Mechanistically, we identified BOC mRNA, a member of the immunoglobulin superfamily of cell adhesion molecules, as a direct target of NAT10-catalyzed ac4C modification. This modification enhances both the stability and translational efficiency of BOC mRNA, thereby contributing to GBM progression. Furthermore, we demonstrate that HIF1\u03b1, a key transcription factor in the hypoxic response, directly activates NAT10 transcription by binding to hypoxia response elements HRE1 and HRE2, leading to increased ac4C modification of BOC mRNA under hypoxic conditions. Notably, pharmacological inhibition of NAT10 effectively suppresses its enzymatic activity, particularly under hypoxia, underscoring its potential as a therapeutic target in GBM. In summary, our findings reveal a critical role for NAT10-mediated mRNA ac4C modification in GBM oncogenesis and highlight NAT10 as a promising target for therapeutic intervention.<\/jats:p>","DOI":"10.1038\/s41419-025-08315-3","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:52:59Z","timestamp":1767883979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NAT10-mediated ac4C modifications regulate glioblastoma progression"],"prefix":"10.1038","volume":"17","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PengXiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhansheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-3239","authenticated-orcid":false,"given":"Longbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-8021","authenticated-orcid":false,"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-7880","authenticated-orcid":false,"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"8315_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","volume":"9","author":"A Bikfalvi","year":"2023","unstructured":"Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, et al. Challenges in glioblastoma research: focus on the tumor microenvironment. Trends Cancer. 2023;9:9\u201327.","journal-title":"Trends Cancer"},{"key":"8315_CR2","doi-asserted-by":"crossref","unstructured":"Fabian D, Guillermo Prieto Eibl MDP, Alnahhas I, Sebastian N, Giglio P, Puduvalli V, et al. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review. Cancers. 2019;11.","DOI":"10.3390\/cancers11020174"},{"key":"8315_CR3","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA. 2015;314:2535\u201343.","journal-title":"JAMA"},{"key":"8315_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:31.","journal-title":"J Hematol Oncol"},{"key":"8315_CR5","doi-asserted-by":"crossref","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133.","DOI":"10.1172\/JCI163446"},{"key":"8315_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13:877\u2013919.","journal-title":"Protein Cell"},{"key":"8315_CR7","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of Cytidine in mRNA Promotes Translation Efficiency. Cell. 2018;175:1872\u201386.e24.","journal-title":"Cell"},{"key":"8315_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70026","volume":"5","author":"Z Gu","year":"2024","unstructured":"Gu Z, Zou L, Pan X, Yu Y, Liu Y, Zhang Z, et al. The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression. MedComm (2020). 2024;5:e70026.","journal-title":"MedComm (2020)"},{"key":"8315_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","volume":"33","author":"L Liao","year":"2023","unstructured":"Liao L, He Y, Li SJ, Yu XM, Liu ZC, Liang YY, et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023;33:355\u201371.","journal-title":"Cell Res"},{"key":"8315_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, et al. NAT10\/ac4C\/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. Adv Sci. 2023;10:e2302705.","journal-title":"Adv Sci"},{"key":"8315_CR11","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, et al. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Cancer Res. 2023;83:1666\u201383.","journal-title":"Cancer Res"},{"key":"8315_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature05246","volume":"444","author":"A Okada","year":"2006","unstructured":"Okada A, Charron F, Morin S, Shin DS, Wong K, Fabre PJ, et al. Boc is a receptor for sonic hedgehog in the guidance of commissural axons. Nature. 2006;444:369\u201373.","journal-title":"Nature"},{"key":"8315_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.devcel.2014.08.010","volume":"31","author":"F Mille","year":"2014","unstructured":"Mille F, Tamayo-Orrego L, L\u00e9vesque M, Remke M, Korshunov A, Cardin J, et al. The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors. Dev Cell. 2014;31:34\u201347.","journal-title":"Dev Cell"},{"key":"8315_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neuron.2019.04.003","volume":"102","author":"J Ferent","year":"2019","unstructured":"Ferent J, Gigu\u00e8re F, Jolicoeur C, Morin S, Michaud JF, Makihara S, et al. Boc Acts via Numb as a Shh-Dependent Endocytic Platform for Ptch1 Internalization and Shh-Mediated Axon Guidance. Neuron. 2019;102:1157\u201371.e5.","journal-title":"Neuron"},{"key":"8315_CR15","doi-asserted-by":"crossref","unstructured":"Echevarr\u00eda-Andino ML, Allen BL. The hedgehog co-receptor BOC differentially regulates SHH signaling during craniofacial development. Development. 2020;147.","DOI":"10.1101\/2020.02.04.934497"},{"key":"8315_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111037","volume":"216","author":"S Wang","year":"2024","unstructured":"Wang S, Wang Y, Hao L, Chen B, Zhang J, Li X, et al. BOC targets SMO to regulate the Hedgehog pathway and promote proliferation, migration, and invasion of glioma cells. Brain Res Bull. 2024;216:111037.","journal-title":"Brain Res Bull"},{"key":"8315_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.005","volume":"98","author":"R Verdikt","year":"2024","unstructured":"Verdikt R, Thienpont B. Epigenetic remodelling under hypoxia. Semin Cancer Biol. 2024;98:1\u201310.","journal-title":"Semin Cancer Biol"},{"key":"8315_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S. The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review. Mol Ther Nucleic Acids. 2020;20:13\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8315_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen D, Xu L, Xing H, Shen W, Song Z, Li H, et al. Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. Imeta. 2024;3:e238.","journal-title":"Imeta"},{"key":"8315_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8315_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-physiol-031620-094324","volume":"83","author":"KD Walton","year":"2021","unstructured":"Walton KD, Gumucio DL. Hedgehog signaling in intestinal development and homeostasis. Annu Rev Physiol. 2021;83:359\u201380.","journal-title":"Annu Rev Physiol"},{"key":"8315_CR22","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1101\/gad.1951710","volume":"24","author":"PA Beachy","year":"2010","unstructured":"Beachy PA, Hymowitz SG, Lazarus RA, Leahy DJ, Siebold C. Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev. 2010;24:2001\u201312.","journal-title":"Genes Dev"},{"key":"8315_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-025-00286-3","volume":"6","author":"L Jiao","year":"2025","unstructured":"Jiao L, Si Y, Yuan Y, Lei X, Jiang Q, Yang L, et al. Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed. 2025;6:46.","journal-title":"Mol Biomed"},{"key":"8315_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2017.09.055","volume":"412","author":"JY Yin","year":"2018","unstructured":"Yin JY, Zhang JT, Zhang W, Zhou HH, Liu ZQ. eIF3a: A new anticancer drug target in the eIF family. Cancer Lett. 2018;412:81\u20137.","journal-title":"Cancer Lett"},{"key":"8315_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177.","journal-title":"Mol Cancer"},{"key":"8315_CR26","doi-asserted-by":"crossref","unstructured":"Yang Q, Lei X, He J, Peng Y, Zhang Y, Ling R, et al. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10\/SEPT9\/HIF-1\u03b1 Positive Feedback Loop. Adv Sci. 2023:e2300898.","DOI":"10.1002\/advs.202300898"},{"key":"8315_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014;344:527\u201332.","journal-title":"Science"},{"key":"8315_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen A, Thomas JM, Matzov D, Taoka M, Nance KD, Nir R, et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature. 2020;583:638\u201343.","journal-title":"Nature"},{"key":"8315_CR29","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/nar\/gkv075","volume":"43","author":"S Sharma","year":"2015","unstructured":"Sharma S, Langhendries JL, Watzinger P, K\u00f6tter P, Entian KD, Lafontaine DL. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Res. 2015;43:2242\u201358.","journal-title":"Nucleic Acids Res"},{"key":"8315_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6:173.","journal-title":"Signal Transduct Target Ther"},{"key":"8315_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J, et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12:e738.","journal-title":"Clin Transl Med"},{"key":"8315_CR32","doi-asserted-by":"crossref","unstructured":"Li KJ, Hong Y, Yu YZ, Xie Z, Lv DJ, Wang C, et al. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8. Adv Sci. 2024:e2310131.","DOI":"10.1002\/advs.202310131"},{"key":"8315_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15252\/embr.201540505","volume":"17","author":"X Liu","year":"2016","unstructured":"Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17:349\u201366.","journal-title":"EMBO Rep"},{"key":"8315_CR34","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu HY, Liu YY, Yang F, Zhang L, Zhang FL, Hu X, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020;48:3638\u201356.","journal-title":"Nucleic Acids Res"},{"key":"8315_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbrc.2003.09.235","volume":"311","author":"J Lv","year":"2003","unstructured":"Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B. Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun. 2003;311:506\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"8315_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.yexcr.2009.03.007","volume":"315","author":"Q Shen","year":"2009","unstructured":"Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, et al. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res. 2009;315:1653\u201367.","journal-title":"Exp Cell Res"},{"key":"8315_CR37","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.devcel.2011.04.017","volume":"20","author":"L Izzi","year":"2011","unstructured":"Izzi L, L\u00e9vesque M, Morin S, Laniel D, Wilkes BC, Mille F, et al. Boc and Gas1 each form distinct Shh receptor complexes with Ptch1 and are required for Shh-mediated cell proliferation. Dev Cell. 2011;20:788\u2013801.","journal-title":"Dev Cell"},{"key":"8315_CR38","doi-asserted-by":"crossref","unstructured":"Pedrosa R, Wismans LV, Sinke R, van der Weiden M, van Eijck CHJ, Kros JM, et al. Differential Expression of BOC, SPOCK2, and GJD3 Is Associated with Brain Metastasis of ER-Negative Breast Cancers. Cancers. 2021;13.","DOI":"10.3390\/cancers13122982"},{"key":"8315_CR39","doi-asserted-by":"publisher","first-page":"17392","DOI":"10.1002\/jcp.28361","volume":"234","author":"M Wei","year":"2019","unstructured":"Wei M, Ma R, Huang S, Liao Y, Ding Y, Li Z, et al. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1\u03b1\/hedgehog pathway under hypoxia. J Cell Physiol. 2019;234:17392\u2013404.","journal-title":"J Cell Physiol"},{"key":"8315_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1242\/dev.057950","volume":"138","author":"SA Bergeron","year":"2011","unstructured":"Bergeron SA, Tyurina OV, Miller E, Bagas A, Karlstrom RO. Brother of cdo (umleitung) is cell-autonomously required for Hedgehog-mediated ventral CNS patterning in the zebrafish. Development. 2011;138:75\u201385.","journal-title":"Development"},{"key":"8315_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70015","volume":"6","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G, et al. RNA N4-acetylcytidine modification and its role in health and diseases. MedComm (2020). 2025;6:e70015.","journal-title":"MedComm (2020)"},{"key":"8315_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11010-020-03776-w","volume":"472","author":"Y Wu","year":"2020","unstructured":"Wu Y, Cao Y, Liu H, Yao M, Ma N, Zhang B. Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells. Mol Cell Biochem. 2020;472:19\u201331.","journal-title":"Mol Cell Biochem"},{"key":"8315_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehae707","volume":"46","author":"C Yu","year":"2025","unstructured":"Yu C, Chen Y, Luo H, Lin W, Lin X, Jiang Q, et al. NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur Heart J. 2025;46:288\u2013304.","journal-title":"Eur Heart J"},{"key":"8315_CR44","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9:e96801.","journal-title":"PLoS One"},{"key":"8315_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13046-023-02640-1","volume":"42","author":"Z Tu","year":"2023","unstructured":"Tu Z, Wang C, Hu Q, Tao C, Fang Z, Lin L, et al. Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy. J Exp Clin Cancer Res. 2023;42:77.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08315-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:35:06Z","timestamp":1770298506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08315-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8315"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08315-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study involving human samples has been approved by the ethics committee of the Second Affiliated Hospital of Nanchang University (NCULAE-20221031029). All animal experiments were approved by the ethics committee of the Second Affiliated Hospital of Nanchang University (0-2024130).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics requirements"}}],"article-number":"181"}}